Impact of metformin use on the outcomes of newly diagnosed diffuse large B-cell lymphoma and follicular lymphoma

The diabetes mellitus (DM) drug metformin targets mechanistic/mammalian target of rapamycin and inhibits lymphoma growth in vitro. We investigated whether metformin affected outcomes of newly diagnosed diffuse large B-cell (DLBCL, n = 869) and follicular lymphoma (FL, n = 895) patients enrolled in t...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Br J Haematol
Hlavní autoři: Wang, Yucai, Maurer, Matthew J., Larson, Melissa C., Allmer, Cristine, Feldman, Andrew L., Bennani, N. Nora, Thompson, Carrie A., Porrata, Luis F., Habermann, Thomas M., Witzig, Thomas E., Ansell, Stephen M., Slager, Susan L., Nowakowski, Grzegorz S., Cerhan, James R.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6731132/
https://ncbi.nlm.nih.gov/pubmed/31135975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.15997
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky